SCHEMBL5180830

SCHEMBL5180830

Cc1ccc(NC(=S)NN=Cc2cccnc2)c(C)c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.60
▸ ALOX12 P18054 3/20 0.60
▸ HTT P42858 1/20 0.60
▸ GAA P10253 2/20 0.58
▸ ALDH1A1 P00352 5/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ PKM P14618 1/20 0.54
▸ CTH P32929 2/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.53
▸ POLB P06746 3/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ PSMD14 O00487 1/20 0.51
▸ RECQL P46063 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6847021 1.00 MAPT (0.60) MAPTALOX12HTTGAAALDH1A1
SCHEMBL6848013 0.85 MAPT (0.61) MAPTALOX12HTTGAAALDH1A1
SCHEMBL5180461 0.85 MAPT (0.61) MAPTALOX12HTTGAAALDH1A1
SCHEMBL5181467 0.85 ALOX12 (0.67) MAPTALOX12HTTGAAALDH1A1
SCHEMBL5181464 0.85 ALOX12 (0.67) MAPTALOX12HTTGAAALDH1A1
SCHEMBL28255841 0.81 GFER (0.65) MAPTHTTGAAALDH1A1KDM4E
SCHEMBL5182078 0.81 GAA (0.72) MAPTALOX12HTTGAAKDM4E
SCHEMBL5182463 0.81 GAA (0.72) MAPTALOX12HTTGAAKDM4E
SCHEMBL5180111 0.80 MAPT (0.71) MAPTALOX12HTTGAAALDH1A1
SCHEMBL5179596 0.80 MAPT (0.71) MAPTALOX12HTTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399159-A4 4-SUBSTITUTED-1-(ARYLMETHYLIDENE)THIOSEMICARBAZIDE, 4-SUBSTITUTED-1-(ARYLCARBONYL)THIOSEMICARBAZIDE AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2007-02-14 — — EP disclosed
US-6794400-B2 USE AS ANTICANCER AGENTS AND IN OTHER CONDITIONS INVOLVING ABNORMAL CELL PROLIFERATION SUCH AS RHEUMATOID ARTHRITIS CYTOVIA, INC. 2004-09-21 — — US disclosed
EP-1399159-A1 4-SUBSTITUTED-1-(ARYLMETHYLIDENE)THIOSEMICARBAZIDE, 4-SUBSTITUTED-1-(ARYLCARBONYL)THIOSEMICARBAZIDE AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2004-03-24 — — EP disclosed
US-20030045581-A1 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof DISCOVER GROWTH FUND, LLC (VI) 2003-03-06 — — US disclosed
WO-2002098420-A1 4-SUBSTITUTED-1-(ARYLMETHYLIDENE)THIOSEMICARBAZIDE, 4-SUBSTITUTED-1-(ARYLCARBONYL)THIOSEMICARBAZIDE AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-12-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045581-A1 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP1, CASP3, CASP4 MAPT 4822/4885ALOX12 3136/4885HTT 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback